Evidence map›Paper›PMID 32797041›Full record

ArticlePLoS neglected tropical diseases2020

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation.

Susana A Besuschio, Albert Picado, Arturo Muñoz-Calderón, Diana P Wehrendt, Marisa Fernández, Alejandro Benatar, Zoraida Diaz-Bello, Cecilia Irurtia, Israel Cruz, Joseph M Ndung'u and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Chagas Disease: An Opportunistic Infection in AIDS.Current infectious disease reports · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Chagas Disease: A Silent Threat for Dogs and Humans.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Frontiers in microbiology · 2024
    Article
  12. Article
  13. Clinical use of molecular methods forFrontiers in parasitology · 2023
    Article
  14. Laboratory diagnosis ofFrontiers in parasitology · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 4 countries.

Susana A BesuschioLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.
Albert PicadoFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Arturo Muñoz-CalderónLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.
Diana P WehrendtLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.
Marisa FernándezHospital de Enfermedades Infecciosas "Dr. Francisco J. Muñiz" Buenos Aires, Argentina.
Alejandro BenatarLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.ORCID 0000-0003-1654-5374
Zoraida Diaz-BelloInstituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela 5.
Cecilia IrurtiaHospital Nacional "Profesor Alejandro Posadas", Villa Sarmiento, Buenos Aires, Argentina.
Israel CruzFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Joseph M Ndung'uFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
María L CafferataDepartamento en Salud de la Madre y el Niño, Instituto de Efectividad Clínica y Sanitaria - Centro de Investigación en Epidemiología y Salud Pública (IECS-CIESP), Buenos Aires, Argentina.
Graciela MontenegroHospital Nacional "Profesor Alejandro Posadas", Villa Sarmiento, Buenos Aires, Argentina.
Sergio Sosa EstaniInstituto Nacional de Parasitología, "Dr Mario Fatala Chabén", ANLIS CG Malbrán, Buenos Aires, Argentina.
Raúl H LuceroÁrea de Biología Molecular, Instituto de Medicina Regional, Universidad Nacional del Nordeste, Resistencia, Argentina.
Belkisyole Alarcón de NoyaInstituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela 5.
Silvia A LonghiLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.
Alejandro G SchijmanLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres", (INGEBI-CONICET), Buenos Aires, Argentina.ORCID 0000-0001-9805-3415
Consejo Nacional de Investigaciones Científicas y Técnicas · ARFIND · CHAdministración Nacional de Laboratorios e Institutos de Salud · ARCentral University of Venezuela · VEHospital Posadas · ARInstituto de Efectividad Clínica y Sanitaria · ARNational University of the Northeast · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Trypanosoma cruzi Loopamp kit was recently developed as a ready-to-use diagnostic method requiring minimal laboratory facilities. We evaluated its diagnostic accuracy for detection of acute Chagas disease (CD) in different epidemiological and clinical scenarios. In this retrospective study, a convenience series of clinical samples (venous blood treated with EDTA or different stabilizer agents, heel-prick blood in filter paper or cerebrospinal fluid samples (CSF)) from 30 infants born to seropositive mothers (13 with congenital CD and 17 noninfected), four recipients of organs from CD donors, six orally-infected cases after consumption of contaminated guava juice and six CD patients coinfected with HIV at risk of CD reactivation (N = 46 patients, 46 blood samples and 1 CSF sample) were tested by T. cruzi Loopamp kit (Tc LAMP) and standardized quantitative real-time PCR (qPCR). T. cruzi Loopamp accuracy was estimated using the case definition in the different groups as a reference. Cohen's kappa coefficient (κ) was applied to measure the agreement between Tc LAMP (index test) and qPCR (reference test). Sensitivity and specificity of T. cruzi Loopamp kit in blood samples from the pooled clinical groups was 93% (95% CI: 77-99) and 100% (95% CI: 80-100) respectively. The agreement between Tc LAMP and qPCR was almost perfect (κ = 0.92, 95% CI: 0.62-1.00). The T. cruzi Loopamp kit was sensitive and specific for detection of T. cruzi infection. It was carried out from DNA extracted from peripheral blood samples (via frozen EDTA blood, guanidine hydrochloride-EDTA blood, DNAgard blood and dried blood spots), as well as in CSF specimens infected with TcI or TcII/V/VI parasite populations. The T. cruzi Loopamp kit appears potentially useful for rapid detection of T. cruzi infection in congenital, acute and CD reactivation due to HIV infection.

Indexed as

Chagas DiseaseCoinfectionDNA, ProtozoanFemaleHIV InfectionsHumansInfantInfant, NewbornMaleNucleic Acid Amplification TechniquesReal-Time Polymerase Chain ReactionRetrospective StudiesSensitivity and SpecificityTransplant RecipientsTrypanosoma cruziDNA, Protozoan

Identifiers

PMID32797041
PMCPMC7458301
OpenAlexW3049515492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.